Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.

Eur J Neurol · 2019 · PMC6593867 · PMID 30714278

Europe PMC DOI

hedged sentence

0.1300

closest p · 2.6× alpha

0.1300

boldest claim

The sentences

did not reach statistical significanceP = 0.13not close (p > 0.1)

Overall, amongst the 23 patients tested, anti‐neuronal cell‐surface antibodies were detected more frequently in those with recurrent (4/6, 67%) than in those with monophasic thymoma (4/17, 24%), but this difference did not reach statistical significance ( P = 0.13).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.